Details of Drug-Drug Interaction
| Drug General Information (ID: DDIWIDTKOH) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Inulin | Drug Info | Linaclotide | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Hypoglycemic Agents | Guanylate Cyclase-C Agonists | |||||||
| Structure | |||||||||
| Mechanism of Inulin-Linaclotide Interaction (Severity Level: Minor) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Increased risk of other adverse reactions (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Inulin | Linaclotide | |||||||
| Mechanism | Diarrhea | Diarrhea | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Adverse reactions | ||||||||
| Factor Description | An adverse reaction is an unexpected negative reaction to a medication or treatment that happens even when it's used correctly. | ||||||||
| Mechanism Description |
|
||||||||
| References | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.". | ||||||||||||||||||
| 2 | Product Information. Linzess (linaclotide). Forest Pharmaceuticals, St. Louis, MO. | ||||||||||||||||||
